Multi-omics profiling in spinal muscular atrophy (SMA): investigating lipid and metabolic alterations through longitudinal CSF analysis of Nusinersen-treated patients
Journal of Neurology · 2025-03 · 272 (3)
DOI: 10.1007/s00415-025-12909-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neurology, online erschienen am 04.02.2025. Verfasst von Martina Zandl-Lang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Research Unit of Analytical Mass Spectrometry, Cell Biology and Biochemistry of Inborn Errors of Metabolism, Department of Paediatrics and Adolescent…. Hauptthemen laut MEDLINE: Oligonucleotides, Muscular Atrophy, Spinal, Lipid Metabolism. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Science Fund, Medical University of Graz.
Abstract (Originalsprache)
Spinal muscular atrophy (SMA) is a rare neuromuscular disease caused by biallelic mutations in the SMN1 gene, leading to progressive muscle weakness due to degeneration of the anterior horn cells. Since 2017, SMA patients can be treated with the anti-sense oligonucleotide Nusinersen, which promotes alternative splicing of the SMN2 gene, by regular intrathecal injections. In this prospective study, we applied metabolomic, lipidomic, and proteomic analysis to examine sequential CSF samples from 13 SMA patients and controls. This multi-omic approach identified over 800 proteins and 400 small molecules including lipids. Multivariate analysis of multi-omic data successfully discriminated between the CSF derived from SMA patients and control subjects. Lipidomic analysis revealed increased levels of cholesteryl esters and lyso-phospholipids, along with reduced levels of cholesterol and phospholipids in the CSF of SMA patients as compared to healthy controls. These data, combined with results from functional assays, led us to conclude that SMA patients exhibit altered levels and function of high-density-lipoprotein (HDL)-like particles in the CSF. Notably, Nusinersen therapy was observed to reverse disease-specific profile changes toward a physiological state, potentially explicable by restoring HDL function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Unit of Analytical Mass Spectrometry, Cell Biology and Biochemistry of Inborn Errors of Metabolism, Department of Paediatrics and Adolescent Medicine, Medical University of Graz, 8036, Graz, Austria. martina.za…
- Institute of Molecular Biosciences, University of Graz, 8010, Graz, Austria.
- Division of Pharmacology, Otto Loewi Research Center for Vascular Biology, Immunology and Inflammation, Medical University of Graz, 8010, Graz, Austria.
- Core Facility Mass Spectrometry, ZMF, Medical University of Graz, 8036, Graz, Austria.
- Division of General Pediatrics, Department of Pediatrics, Medical University of Graz, 8036, Graz, Austria.
- Department of Paediatrics, University Children's Hospital Linz, 4020, Linz, Austria.
Förderung
- Austrian Science Fund
- Medical University of Graz
Zitieren
APA
Zandl-Lang, M., Züllig, T., Holzer, M., Eichmann, T. O., Darnhofer, B., Schwerin-Nagel, A., Zobel, J., Haidl, H., Biebl, A., Köfeler, H., & Plecko, B. (2025). Multi-omics profiling in spinal muscular atrophy (SMA): investigating lipid and metabolic alterations through longitudinal CSF analysis of Nusinersen-treated patients. Journal of Neurology, 272(3). https://doi.org/10.1007/s00415-025-12909-4
Vancouver
Zandl-Lang M, Züllig T, Holzer M, Eichmann TO, Darnhofer B, Schwerin-Nagel A, et al. Multi-omics profiling in spinal muscular atrophy (SMA): investigating lipid and metabolic alterations through longitudinal CSF analysis of Nusinersen-treated patients. Journal of Neurology. 2025;272(3). doi:10.1007/s00415-025-12909-4
BibTeX
@article{ZandlLang2025,
author = {Zandl-Lang, Martina and Züllig, Thomas and Holzer, Michael and Eichmann, Thomas O and Darnhofer, Barbara and Schwerin-Nagel, Annette and Zobel, Joachim and Haidl, Harald and Biebl, Ariane and Köfeler, Harald and Plecko, Barbara},
title = {Multi-omics profiling in spinal muscular atrophy (SMA): investigating lipid and metabolic alterations through longitudinal CSF analysis of Nusinersen-treated patients},
journal = {Journal of Neurology},
year = {2025},
volume = {272},
number = {3},
doi = {10.1007/s00415-025-12909-4}
}
EUVIMED